E2F-1 is a critical modulator of cellular senescence in human cancer
Chaehwa Park(Samsung (South Korea)), Won Ki Kang(Samsung Medical Center)
Cited by 54
Related Papers
Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients
|Annals of Oncology|2018|105
ARTIST 2: Interim results of a phase III trial involving adjuvant chemotherapy and/or chemoradiotherapy after D2-gastrectomy in stage II/III gastric cancer (GC).
|Journal of Clinical Oncology|2019|79
RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis
|Scientific Reports|2019|10